Logo image of SNW.DE

SANOFI (SNW.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:SNW - FR0000120578 - Common Stock

83.44 EUR
-0.28 (-0.33%)
Last: 12/12/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, SNW scores 5 out of 10 in our fundamental rating. SNW was compared to 53 industry peers in the Pharmaceuticals industry. SNW has an excellent profitability rating, but there are some minor concerns on its financial health. SNW has a correct valuation and a medium growth rate. SNW also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

SNW had positive earnings in the past year.
SNW had a positive operating cash flow in the past year.
Each year in the past 5 years SNW has been profitable.
SNW had a positive operating cash flow in each of the past 5 years.
SNW.DE Yearly Net Income VS EBIT VS OCF VS FCFSNW.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

Looking at the Return On Assets, with a value of 11.05%, SNW is in the better half of the industry, outperforming 75.47% of the companies in the same industry.
With a decent Return On Equity value of 19.73%, SNW is doing good in the industry, outperforming 64.15% of the companies in the same industry.
With a decent Return On Invested Capital value of 13.84%, SNW is doing good in the industry, outperforming 66.04% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SNW is significantly below the industry average of 13.94%.
The last Return On Invested Capital (13.84%) for SNW is above the 3 year average (7.31%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROIC 13.84%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
SNW.DE Yearly ROA, ROE, ROICSNW.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of SNW (20.35%) is better than 77.36% of its industry peers.
In the last couple of years the Profit Margin of SNW has grown nicely.
SNW has a Operating Margin (23.59%) which is in line with its industry peers.
SNW's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 71.70%, SNW is in line with its industry, outperforming 50.94% of the companies in the same industry.
In the last couple of years the Gross Margin of SNW has remained more or less at the same level.
Industry RankSector Rank
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
SNW.DE Yearly Profit, Operating, Gross MarginsSNW.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SNW is creating some value.
Compared to 1 year ago, SNW has about the same amount of shares outstanding.
SNW has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, SNW has an improved debt to assets ratio.
SNW.DE Yearly Shares OutstandingSNW.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
SNW.DE Yearly Total Debt VS Total AssetsSNW.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

SNW has a debt to FCF ratio of 2.21. This is a good value and a sign of high solvency as SNW would need 2.21 years to pay back of all of its debts.
SNW has a Debt to FCF ratio of 2.21. This is in the better half of the industry: SNW outperforms 79.25% of its industry peers.
SNW has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.21, SNW is in the better half of the industry, outperforming 71.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Altman-Z N/A
ROIC/WACC1.77
WACC7.82%
SNW.DE Yearly LT Debt VS Equity VS FCFSNW.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

A Current Ratio of 1.27 indicates that SNW should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.27, SNW is doing worse than 62.26% of the companies in the same industry.
A Quick Ratio of 0.94 indicates that SNW may have some problems paying its short term obligations.
SNW has a Quick ratio (0.94) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.94
SNW.DE Yearly Current Assets VS Current LiabilitesSNW.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

SNW shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.35%.
Measured over the past 5 years, SNW shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
SNW shows a small growth in Revenue. In the last year, the Revenue has grown by 2.56%.
The Revenue has been growing slightly by 3.31% on average over the past years.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%

3.2 Future

SNW is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.11% yearly.
Based on estimates for the next years, SNW will show a small growth in Revenue. The Revenue will grow by 4.55% on average per year.
EPS Next Y3.02%
EPS Next 2Y5.77%
EPS Next 3Y5.98%
EPS Next 5Y7.11%
Revenue Next Year0.64%
Revenue Next 2Y3.51%
Revenue Next 3Y4.42%
Revenue Next 5Y4.55%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SNW.DE Yearly Revenue VS EstimatesSNW.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
SNW.DE Yearly EPS VS EstimatesSNW.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.98, which indicates a very decent valuation of SNW.
Compared to the rest of the industry, the Price/Earnings ratio of SNW indicates a rather cheap valuation: SNW is cheaper than 83.02% of the companies listed in the same industry.
SNW's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.56.
The Price/Forward Earnings ratio is 9.71, which indicates a very decent valuation of SNW.
83.02% of the companies in the same industry are more expensive than SNW, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.79, SNW is valued rather cheaply.
Industry RankSector Rank
PE 10.98
Fwd PE 9.71
SNW.DE Price Earnings VS Forward Price EarningsSNW.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SNW is valued a bit cheaper than the industry average as 66.04% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as SNW.
Industry RankSector Rank
P/FCF 20.12
EV/EBITDA 10.69
SNW.DE Per share dataSNW.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of SNW may justify a higher PE ratio.
PEG (NY)3.64
PEG (5Y)2.15
EPS Next 2Y5.77%
EPS Next 3Y5.98%

8

5. Dividend

5.1 Amount

SNW has a Yearly Dividend Yield of 4.69%, which is a nice return.
SNW's Dividend Yield is rather good when compared to the industry average which is at 1.83. SNW pays more dividend than 88.68% of the companies in the same industry.
SNW's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 4.69%

5.2 History

The dividend of SNW has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SNW.DE Yearly Dividends per shareSNW.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

34.82% of the earnings are spent on dividend by SNW. This is a low number and sustainable payout ratio.
SNW's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.82%
EPS Next 2Y5.77%
EPS Next 3Y5.98%
SNW.DE Yearly Income VS Free CF VS DividendSNW.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
SNW.DE Dividend Payout.SNW.DE Dividend Payout, showing the Payout Ratio.SNW.DE Dividend Payout.PayoutRetained Earnings

SANOFI

FRA:SNW (12/12/2025, 7:00:00 PM)

83.44

-0.28 (-0.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-24 2025-10-24/bmo
Earnings (Next)01-28 2026-01-28/amc
Inst Owners46.31%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap202.68B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target107.41 (28.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.69%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)0.93%
PT rev (3m)-2.41%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)-0.86%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-1.69%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.93%
Valuation
Industry RankSector Rank
PE 10.98
Fwd PE 9.71
P/S 2.99
P/FCF 20.12
P/OCF 17.81
P/B 2.9
P/tB 21.81
EV/EBITDA 10.69
EPS(TTM)7.6
EY9.11%
EPS(NY)8.59
Fwd EY10.3%
FCF(TTM)4.15
FCFY4.97%
OCF(TTM)4.69
OCFY5.61%
SpS27.95
BVpS28.82
TBVpS3.83
PEG (NY)3.64
PEG (5Y)2.15
Graham Number70.2
Profitability
Industry RankSector Rank
ROA 11.05%
ROE 19.73%
ROCE 16.7%
ROIC 13.84%
ROICexc 16.48%
ROICexgc 66.95%
OM 23.59%
PM (TTM) 20.35%
GM 71.7%
FCFM 14.83%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.21
Debt/EBITDA 0.75
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 58.05%
Profit Quality 72.91%
Current Ratio 1.27
Quick Ratio 0.94
Altman-Z N/A
F-Score7
WACC7.82%
ROIC/WACC1.77
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y3.02%
EPS Next 2Y5.77%
EPS Next 3Y5.98%
EPS Next 5Y7.11%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year0.64%
Revenue Next 2Y3.51%
Revenue Next 3Y4.42%
Revenue Next 5Y4.55%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year29.46%
EBIT Next 3Y13.42%
EBIT Next 5Y11.66%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%

SANOFI / SNW.DE FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to SNW.DE.


Can you provide the valuation status for SANOFI?

ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SNW.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for SANOFI?

SANOFI (SNW.DE) has a profitability rating of 7 / 10.


What is the financial health of SANOFI (SNW.DE) stock?

The financial health rating of SANOFI (SNW.DE) is 4 / 10.


What is the expected EPS growth for SANOFI (SNW.DE) stock?

The Earnings per Share (EPS) of SANOFI (SNW.DE) is expected to grow by 3.02% in the next year.